GE Introduces Healthcare Technology Company to Revolutionize Blood Collection
November 29 2017 - 6:00AM
Business Wire
Drawbridge Health to simplify the collection
and transport of blood samples
Today, GE introduced Drawbridge Health, a privately-held
healthcare technology company focused on enabling personal
diagnostic testing — anytime, anywhere. Drawbridge Health is
developing proprietary technology designed to integrate draw,
collection and sample stabilization into a single device.
Healthcare providers will be able to deliver a superior patient
experience, eliminating the need for phlebotomy and travel to blood
draw centers. This integrated technology is also being developed to
support room temperature shipping and streamlined downstream
processing, ensuring reliable, accurate results. Through this
integration of engineering and proprietary chemistry, Drawbridge
Health is developing a people-friendly system for drawing and
stabilizing blood samples.
The Drawbridge solution is being designed to offer a way for
healthcare providers and diagnostic testing companies to better
engage their patient-consumers and help enable them to manage their
own health — driving a shift from reacting to tracking. By
introducing a simple, comfortable blood draw solution, Drawbridge
Health can alter the market for patients and healthcare providers
by broadening the availability and access for molecular tests for a
variety of diseases, as well as providing a convenient way to
monitor overall health, therapy response and disease
progression.
“At GE we share technology, markets, structure and knowledge
across our varied businesses, which uniquely positions us to tackle
many issues, including this one,” said Risa Stack, Managing
Director of New Business Creation, GE Ventures. “With Drawbridge
Health, we are combining technology from GE Global Research,
expertise from GE Healthcare and business models from GE Ventures
to offer a simple, safe and more efficient solution that can help
save time, money and lives.”
Lee McCracken joined Drawbridge Health as Chief Executive
Officer and the company’s Board of Directors, bringing more than 25
years of experience developing and growing businesses across the
biotech, pharma and diagnostics sectors. Previously, he served as
CEO of Gensignia Life Sciences, a molecular diagnostics company
focused on the early detection of lung cancer through the
integration of miRNA biology and digital health algorithms. Lee
holds a BS in Commerce from Santa Clara University, a Master of
Computer Science from the University of Dayton and an MBA from the
Anderson School of Management at UCLA.
“At Drawbridge Health, we have a tremendous opportunity to
uniquely enable not only effortless access to diagnostic testing,
but to also transform how diagnostics companies and healthcare
providers interact with their patient-consumers,” said Lee
McCracken, CEO, Drawbridge Health. “The current sample testing
process is inconvenient and challenging for patients and medical
providers, alike. It requires clinical processing equipment, often
a technician specifically trained to draw blood, plus a trip to the
doctor’s office or hospital. By combining world class GE technology
and a talented founding team to address an important market need,
Drawbridge Health is well positioned to transform diagnostic
testing for healthcare stakeholders, testing laboratories, patients
and consumers.”
Drawbridge Health is led by Lee McCracken, Chief Executive
Officer, along with Board Members, Risa Stack, General Manager of
New Business Creation at GE Ventures, and Ger Brophy, General
Manager of Cell Therapy at GE Healthcare Life Sciences.
About Drawbridge Health
Drawbridge Health is focused on enabling personal diagnostic
testing – anytime, anywhere. By integrating engineering and
proprietary chemistries, Drawbridge is developing a people-friendly
system for collecting and stabilizing blood samples, opening new
doors to enable access to important health information. At
Drawbridge Health, we’re innovating new ways to put health in your
hands. For more information, please visit
www.drawbridgehealth.com.
About GE Ventures
GE Ventures identifies, scales and accelerates ideas that will
help make the world work better. Focused on the areas of software,
advanced manufacturing, energy and healthcare, GE Ventures combines
equity investing, new business creation, licensing and technology
transfer to deliver an innovation platform designed to drive growth
for partners and GE. For more information, please visit
www.geventures.com or follow on Twitter (@GE_Ventures)
and LinkedIn.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171129005544/en/
GE VenturesKristin Schwarz, +1
646-682-5601kristin.schwarz@ge.comorDrawbridge HealthGreg
Nagy, +1 650-279-3434gnagy@dbhealth.com
GE Aerospace (NYSE:GE)
Historical Stock Chart
From Mar 2024 to Apr 2024
GE Aerospace (NYSE:GE)
Historical Stock Chart
From Apr 2023 to Apr 2024